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The sequential removal of N-acetylneuraminic acid from rabbit serum transferrin has been followed by urea-polyacryl- 
amide gel electrophoresis. The electrophoretic pattern is consistent with the presence of a single biantennary glycan chain. 
From the amino acid sequence of the carbohydrate-containing cyanogen bromide fragment we have shown that the 
glycan is attached to an asparaginyl side chain at a position equivalent to residue 491 in the sequence of human serum 
transferrin. 
Transferrin; Glycan; Amino acid sequence; Cyanogen bromide fragment; (Rabbit) 
1. INTRODUCTION 
The transferrins are a class of iron-binding 
glycoproteins found in serum, egg white, milk and 
other secretory fluids. Although there is extensive 
amino acid sequence homology between the dif- 
ferent transferrins, the number, position and struc- 
ture of the glycan moieties vary [1,2]. The glycan 
chain is always attached to the asparagine residue 
in the code sequence Asn-X-Ser/Thr, where X can 
be almost any amino acid but only rarely proline or 
aspartic acid [3]. In some transferrins this se- 
quence, although present, is not glycosylated, 
possibly because the potential glycosylation site is 
sterically inaccessible to oligosaccharide-pro- 
cessing enzymes. 
In the case of rabbit serum transferrin there is 
agreement on the structure of the glycan chain: a 
biantennary chain with N-acetylneuraminic acid 
residues at the terminal positions [4,5]. There is, 
however, some uncertainty as to whether the pro- 
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tein bears one biantennary glycan [4,6], and thus 
two residues of N-acetylneuraminic acid, or two 
biantennary glycans, and therefore four residues 
of N-acetylneuraminic acid, both located within a 
cyanogen bromide fragment of Mr 24000 [7]. As 
the X-ray structure of rabbit serum transferrin is 
currently under investigation [8] it is important to 
ascertain the number and position of the glycan 
chains in the protein. We have therefore set out to 
re-determine the number of residues of N- 
acetylneuraminic acid, and hence the number of 
glycan chains, on the protein using an elec- 
trophoretic technique previously used to 
demonstrate the presence of a normal amount of 
N-acetylneuraminic acid on a human transferrin 
variant [9], and also pinpoint the position of the 
glycan(s) within the polypeptide chain. This study 
has also extended the amino acid sequence data on 
rabbit transferrin which at present are limited to 
the first 12 residues at the amino terminus [6,10] 
and to those of a carbohydrate-containing pen- 
tapeptide [5]. 
2. MATERIALS AND METHODS 
Transferrin was isolated from iron-saturated rabbit serum by 
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ammonium sulphate precipitation followed by ion-exchange 
chromatography on DEAE-Sepharose. 
Neuraminidase (37.5 U), purchased from BDH, was added to 
0.5 ml rabbit transferrin (10 mg/ml) in 0.1 M sodium 
acetate/O.01 M Ca(NO&, pH 5.0, and the solution incubated 
at 37°C. Samples (40~1) were removed over a period of 48 h 
and diluted to 240 pl with 0.2 M NaHCOs/lO% (w/v) glycerol. 
25 pl of 0.01 M FeNTA was then added and the samples stored 
at - 20°C prior to electrophoresis in the presence of 6 M urea. 
After 24 h an additional sample (50 ~1) was removed, diluted to 
100 pl with the original sodium acetate buffer and incubated for 
24 h with fresh neuraminidase (7.5 U). As a control transferrin 
was incubated for 48 h in the absence of neuraminidase. Pro- 
tein samples were analysed by polyacrylamide gel elec- 
trophoresis in the presence of 6 M urea as described [1 l] except 
that EDTA was omitted from all buffers and the bisacrylamide 
concentration was increased to 0.334% (w/v). 
Iron-free rabbit transferrin was reduced and carbox- 
amidomethylated as described for human transferrin [12] and 
digested with cyanogen bromide [13]. After drying in vacua 
over NaOH pellets the digest was dissolved in 5% (v/v) formic 
acid prior to fractionation on a column (1.6 x 90 cm) of 
Sephacryl S-200 equilibrated with the same buffer. Fractions 
were examined for the presence of carbohydrate by the or- 
cinol/HsS04 test [14] and analysed by SDS-polyacrylamide gel 
electrophoresis. Fractions containing the carbohydrate-positive 
fragment of h4, 24000 were pooled, lyophilised and re- 
chromatographed on the same column to remove small 
amounts of contaminating fragments. 
Amino acid sequencing was carried out using Applied 
Biosystems 477A pulsed liquid and 470A gas-phase protein se- 
quencers with an on-line 120A PTH-amino acid analyser [15]. 
3. RESULTS AND DISCUSSION 
Fig.1 (slots a-j) shows that when rabbit serum 
transferrin is incubated with neuraminidase over a 
period of 48 h there is a two-step reduction in 
mobility of the iron-saturated protein. No addi- 
tional decrease in mobility is observed in a sample 
of transferrin to which has been added fresh 
neuraminidase after 24 h (fig.1, slot k). In a 
separate experiment when both rabbit serum 
transferrin and human serum transferrin were in- 
cubated with neuraminidase over a period of 24 h 
there was once again a two-step decrease in mobili- 
ty of rabbit transferrin whereas a four-step 
decrease in mobility was observed with human 
transferrin. These results are consistent with the se- 
quential removal of two residues of N- 
acetylneuraminic acid from rabbit transferrin. 
This procedure has already been used to 
demonstrate the presence of 4 N-acetylneuraminic 
acid residues in the terminal positions of the 2 
biantennary glycans on normal human serum 
40 
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Fig. 1. Urea-polyacrylamide gel electrophoresis of diferric 
rabbit transferrin incubated with neuraminidase. (a) Diferric 
transferrin. (b-j) Samples taken from reaction mixture at (b) 
10 min. (c) 20 min, (d) 40 min, (e) 1 h, (f) 2 h, (g) 3 h, (h) 4 h, 
(i) 24 h, (j) 48 h. (k) Transferrin incubated for 24 h and a 
further 24 h with fresh neuraminidase. (1) Transferrin incubated 
for 48 h without neuraminidase. 
transferrin and a variant with abnormal iron- 
binding properties [9]. 
From the results with rabbit serum transferrin 
we can conclude that the protein carries a single 
biantennary glycan, with two residues of N- 
acetylneuraminic acid at the terminal positions, in 
agreement with two earlier reports [4,6] rather 
than two biantennary glycans, with 4 residues of 
N-acetylneuraminic acid at the terminal positions 
[7]. The figure of two glycan chains/molecule [7] 
was calculated from the carbohydrate composition 
of a rabbit serum transferrin preparation [16] 
possibly contaminated by haemopexin, a 
carbohydrate-rich protein notoriously difficult to 
remove from serum transferrins. 
All the carbohydrate on rabbit serum transferrin 
has been shown to be located in a cyanogen 
bromide fragment of A4, 24000 [7]. Upon tryptic 
digestion of this fragment a glycopeptide with the 
sequence Asn(CHO)-Ser-Ser-Leu-Cys was isolated 
[5]. In order to determine the position of this pen- 
tapeptide within the protein we have purified the 
carbohydrate-containing cyanogen bromide frag- 
ment from digests, by gel filtration, and subjected 
it to automatic amino acid sequencing. The amino 
acid sequence of the first 63 residues is shown in 
fig.2. At position 27 no amino acid was detected. 
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Fig.2. Sequence of carbohydrate-containing cyanogen bromide fragment of rabbit transferrin. 
The sequence in the fragment from residue 28 to 31 
corresponds to the sequence which follows the 
glycosylated asparagine residue in the tryptic pen- 
tapeptide. The absence of a detectable amino acid 
at position 27 in the fragment is consistent with the 
presence of a glycosylated asparagine residue at 
this position. The tryptic pentapeptide therefore 
corresponds to residues 27-31 in the fragment. 
As the complete amino acid sequences of the 
homologous proteins human serum transferrin 
[17], hen ovotransferrin [18] and human lactofer- 
rin [19] are known it is possible to align the partial 
sequence of the cyanogen bromide fragment from 
rabbit transferrin with that of the three other 
transferrins. We can see from fig.3 that the amino- 
terminal residue in the cyanogen bromide fragment 
from rabbit transferrin corresponds to residue 465 
in the human transferrin sequence, which follows 
a conserved methionine residue, and the glycosyla- 
tion site in the rabbit protein is the result of a 
substitution of an aspartic acid residue at position 
491 by an asparagine residue. This is also thought 
to be the position of the glycosylation site in 
bovine serum transferrin [19]. The X-ray 
crystallographic structure of rabbit serum transfer- 
rin at a resolution of 3.3 A has recently been 
reported [8] and electron density in the region of 
residue 491 has been interpreted in terms of a 
glycan chain which appears to interact, via its ter- 
minal sialic acid, with a region within the N- 
terminal lobe. 
Although we have only tentatively assigned a 
tyrosine to position 51 in the carbohydrate- 
containing fragment from rabbit transferrin 
(fig.2), a tyrosine residue is present at the cor- 
responding position in human serum transferrin, 
hen ovotransferrin and human lactoferrin (fig.3). 
This particular tyrosine is of particular importance 
as X-ray structural studies [8,20] have shown that 
it interacts with the iron atom in the C-terminal 
metal-binding site. 
Two hydrophobic amino acids, valine and 
isoleucine, were found at position 35 in the 
cyanogen bromide fragment from rabbit transfer- 
rin. As the transferrin was isolated from pooled 
rabbit serum there is the possibility of polymor- 
phism at this position, as has been observed at a 
number of positions within the amino acid se- 
quence of hen ovotransferrin [21]. The alignment 
of the region immediately following the 
valine/isoleucine with the sequences of human 
serum transferrin, human lactoferrin and hen 
ovotransferrin (fig.2) was based on that predicted 
for the corresponding N-terminal region using a 
multiple alignment algorithm [22] and supported 
by X-ray structural studies [8,20]. 
In this study we have shown that only one glycan 
chain is present on rabbit serum transferrin and 
located its position within the polypeptide chain. 
At the same time these studies on the 
carbohydrate-containing cyanogen bromide frag- 
ment have extended the rather limited amino acid 
GLLYNRINHCRFDEFFRQGCAPGSQKNSSLCELC+G-----PSVCAPNNREGYYGyT~AFRC~ve-k~D IRST) 
I 
MGLLYNKlNHCRFDEFFSEGCAPGSKKDSSLCKLCMGSCL---NLCEPNNK~GYYGYTGAFRCLV~-KGD R(ST) 
MGLlHNRTGTCNFDEYFSEGCAPGSPPNSRLCQLCQGSGGlPPEKCVASSHEKYFGYTGALRCLV~-KGD (HOT) 
MGLLFNQTGSCKFDEYSFQSCAPGSDPRSNLClCDEE-GENKCVPNSNERYYGYTGAFRCLA~NAGD (HLT) 
Fig.3. Sequence of cyanogen bromide fragment of rabbit transferrin (RST) aligned with human serum transferrin (HST), hen 
ovotransferrin (HOT) and human lactoferrin (HLT). Gaps (-) have been inserted to maximise the homology. 
41 
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sequence data on the protein. Such information is 
required for correct interpretation of the results of 
crystallographic studies on rabbit transferrin [8]. 
Further studies are now in progress to obtain addi- 
tional sequence data from the other cyanogen 
bromide fragments of rabbit serum transferrin. 
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